Merakris Therapeutics
North Carolina, United States · Biotechnology, Health Care, Manufacturing
Merakris Therapeutics is a leading innovator in regenerative medicine focused on developing and commercializing biologically derived products for wound healing and other complex conditions. Leveraging advanced biologic manufacturing capabilities and a robust research pipeline, Merakris is committed to improving patient outcomes and advancing the science of regenerative therapies.
Key facts
- Headquarters
- North Carolina, United States
- Employees
- 24
- Industries
- Biotechnology, Health Care, Manufacturing
- Status
- Private
- Website
- merakris.com
- Company page
Recent activity at Merakris Therapeutics
Leadership
- Roger Ilagan, Chief Scientific Officer
Verified email and direct lines for Merakris Therapeutics’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Employee benefit plans
Merakris Therapeutics files 1 employee benefit plan with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
Merakris Therapeutics in the news
- Merakris Therapeutics Awarded U.S. Department of Veterans - GlobeNewswire (Jun 17, 2026)
- Merakris Therapeutics Provides FDA Update and Reports Interim Findings for MTX-001 in Venous Leg Ulcers - GlobeNewswire (Apr 07, 2026)
- RTP180 | Chris Broderick, Merakris Therapeutics Inc. | Medicine | Season 2022 - PBS (Feb 22, 2022)
- Jonathan Berlent Joins Merakris As SVP, Head Of Strategy And Operations - citybiz (May 09, 2024)
- Merakris Therapeutics Launches Patent-Pending AmnioSurge™ With 360 Medical, Opening New Surgical Revenue Channel - The Manila Times (Sep 08, 2026)
- Jump-Start Healing with New Amniotic Membrane Graft - Review of Optometry (Jan 23, 2021)
- Merakris Therapeutics Receives USPTO Notice of Allowance - GlobeNewswire (Aug 19, 2025)
- Merakris Advances Potentially Pivotal MTX-001 Phase 2/3 Strategy Following FDA Pre-IND Meeting - GlobeNewswire (Oct 27, 2026)
Companies similar to Merakris Therapeutics
- Cerenome, Inc. · Biotechnology, Health Care, Manufacturing, Therapeutics
- SymPhysis Medical · Biotechnology, Health Care, Manufacturing, Therapeutics
- Virax Biolabs · Biotechnology, Health Care, Manufacturing, Therapeutics
- NewcelX · Biotechnology, Health Care, Manufacturing, Therapeutics
- Prokarium · Biotechnology, Health Care, Manufacturing, Therapeutics
About Merakris Therapeutics: questions and answers
What does Merakris Therapeutics do?
Merakris Therapeutics is a leading innovator in regenerative medicine focused on developing and commercializing biologically derived products for wound healing and other complex conditions. Leveraging advanced biologic manufacturing capabilities and a robust research pipeline, Merakris is committed to improving patient outcomes and advancing the science of regenerative therapies.
Where is Merakris Therapeutics headquartered?
Merakris Therapeutics is headquartered in North Carolina, United States.
How many employees does Merakris Therapeutics have?
Merakris Therapeutics has about 24 employees.
What is the latest news on Merakris Therapeutics?
On Apr 10, 2025, Merakris Therapeutics Appoints Roger Ilagan as Chief Scientific Officer
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy